F-Tryptophan PET/CT in Human Cancers

F-Tryptophan PET/CT in Human Cancers
Conditions:   Intracranial Glioma;   Metastatic Brain Tumor;   Breast Cancer;   Neuroendocrine Tumors
Intervention:   Drug: 1-(2-[18F]FLUOROETHYL)-L-Tryptophan
Sponsor:   Barbara Ann Karmanos Cancer Institute

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 28, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine